Levetiracetam Tablet, Film Coated
Product Images NDC 67877-770

Levetiracetam is a medication that is sold in film-coated tablets containing 1000mg. The usual dosage should be determined based on the complete dosage recommendations specified in the package insert. The medication should be stored at 20°C to 25°C (68°F to 77°F), but temperatures between 15°C to 30°C (59°F to 86°F) are also allowed. This medication is made by Alkem Laboratories Ltd., INDIA, and distributed by Ascend Laboratories, LLC, in containers that are tight, light-resistant, and have child-resistant closures. A Medication Guide should be given to each patient by the pharmacist. The label attached to the package should not have any varnished areas with the dimensions of 45 x 30 mm (LXH). The code number of the medication is HP/Drugs/MNB/05/105 PLS00352 with pharmacode 77160101.*

This is a medication called Levetiracetam. Each tablet contains 250 mg of the active ingredient. It should be stored in a tightly closed, light-resistant container that is child-resistant. The usual dosage is indicated in the package insert. It should be stored at controlled room temperature. The medication is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Parsippany, NJ. The package contains 30 tablets with an NDC code of 67877-768-30. The medication guide should be provided to the patient. There is a barcode on the label.*

Each tablet of Levetiracetam USP contains 750 mg of the drug. The tablets are film-coated and the recommended storage temperature is between 15°C and 30°C with excursions permitted between 20°C to 25°C (68°F to 77°F). The medication should be kept in a tightly closed container with a child-resistant closure. Dispensing instructions are included for pharmacists, and patients should be given the accompanying medication guide. The tablets are manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Parsippany, NJ.*

Levetiracetam Tablets, USP 1000 mg is a medication that comes in a unit-dose package of 10 tablets. Each film-coated tablet contains 1000 mg of Levetiracetam, USP. It is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories LLC in Parsippany, NJ. It is important to keep this medication out of children's reach. The storage temperature recommended is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Rom Temperature]. A package insert is provided with complete dosage recommendations.*

Levetiracetam Tablets are prescription medication containing 500 mg of Levetiracetam, USP. The usual recommended dosage is available in the package insert. Pharmacists should dispense the medication guide with every prescription. The tablets must be stored at 20°C (68°F) to 10.25°C (77°F) with permissible excursions between 15°C to 30°C (59°F to 86°F). The packaging is not child-resistant and must be kept away from children. The medication is distributed by Ascend Laboratories and manufactured by Alkem Laboratories.*

Levetiracetam Tablets, USP is a medication used to treat seizures. Each film-coated tablet contains 750 mg of Levetiracetam, USP. This medication is usually prescribed according to the dosage recommendations listed in the package insert. It is recommended to keep the medication stored at a temperature range between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept out of the reach of children. This medication is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Parsippany, NJ. The package contains 10 unit-dose tablets, which are not child-resistant. The pharmacist is advised to dispense the accompanying Medication Guide to each patient.*

This appears to be a table showing the results of a study comparing a placebo to two different dosage levels of a medication called Levetiracetam in relation to some kind of condition or symptom. However, without any additional context or information it is difficult to determine what the study was actually examining or what the percentages represent.*

This is a table that compares the effectiveness of Levetiracetam at two different doses (1000 mg/day and 2000 mg/day) versus a placebo on an unknown variable. The percentages (35.2%, 20.8%, and 6.3%) likely indicate the success rates of the treatment groups, but without additional context or information, it's impossible to determine what they represent.*

This appears to be a comparison of the effectiveness of a Placebo drug (N=104) versus a Levetiracetam drug at a dosage of 3000 mg/day (N=180). The first two percentages, 39.4% and 14.4%, may be referring to the success rates or side effects of the drugs, but without more context it's difficult to determine the exact meaning.*

This appears to be a chart or a table showing two percentages (19.6% and 44.6%) which are likely the results of a study. The names "Placebo" and "Levetiracetam" at the bottom suggest that the study may have been testing the effectiveness of these two treatments. However, without further context or information, it is difficult to provide a more specific description.*

This is a table representing the percentage of patients for a study involving a placebo group and a group taking levetiracetam. The table shows the percentage of patients in the groups at various intervals, but it is unclear what the intervals represent.*